PRCL Research Overview

  • Founded
  • 2014
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

PRCL Research General Information


Developer of oral drug compounds intended to treat psoriasis. The company's compounds specifically inhibit T-cell activity and are created for a special purpose of targeting the exact cause of the disease, enabling physicians to treat their patients in an enhanced way.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 1255 University
  • Suite 1610
  • Montreal, Quebec H3B 3X3
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PRCL Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business Completed Out of Business
1. Early Stage VC 12-May-2014 Completed Startup
To view PRCL Research’s complete valuation and funding history, request access »